Related Experiment Video
Updated: Apr 28, 2026

Multiplex PCR Assay for Typing of Staphylococcal Cassette Chromosome Mec Types I to V in Methicillin-resistant Staphylococcus aureus
Published on: September 5, 2013
Review on Panton Valentine leukocidin toxin carriage among Staphylococcus aureus
1Department of Microbiology, Tri-Chandra Campus, Tribhuvan University, Nepal.
Abstract:
Panton Valentine leukocidin is a toxin making pores in the polymorphonuclear cells which is a virulence factor of some strains of Staphylococcus aureus. Initially it was produced by methicillin susceptible Staphylococcus aureus only. Later with the acquisition of mecA gene has lead it to be PVL positive methicillin resistant Staphylococcus aureus. Since MRSA are resistant to many antibiotics and further they produce a toxin the infections by PVL positive MRSA has become a challenge. PVL positive MRSA a virulent strain of drug resistant superbug MRSA that has spread around the world, has claimed many lives in UK, Europe, USA and Australia. Some strains of superbug attack the healthy young people and kill within 24 hrs. PVL positive Staphylococcus aureus has been reported to be associated with skin and soft tissue infections however they also cause invasive infections and necrotizing pneumonia. These microorganisms known to be community associated have spread to hospitals. Hospital acquired infection by such microorganisms lead to an increase in mortality hence should be controlled before they become prevalent in hospitals.
Insights
Panton Valentine leukocidin (PVL) is a toxin produced by Staphylococcus aureus. PVL-positive methicillin-resistant Staphylococcus aureus (MRSA) strains are a growing global health threat, causing severe infections and increasing mortality.
Area of Science:
- Microbiology
- Infectious Diseases
- Toxicology
Background:
- Panton Valentine leukocidin (PVL) is a Staphylococcus aureus virulence factor that creates pores in polymorphonuclear cells.
- Initially associated with methicillin-susceptible S. aureus, PVL production is now linked to methicillin-resistant S. aureus (MRSA) due to mecA gene acquisition.
- PVL-positive MRSA represents a significant challenge due to antibiotic resistance and potent toxin production.
Purpose of the Study:
- To highlight the increasing threat of PVL-positive MRSA globally.
- To discuss the severe clinical manifestations and high mortality associated with PVL-positive MRSA infections.
- To emphasize the need for control measures against PVL-positive MRSA, particularly in hospital settings.
Main Methods:
- Literature review and synthesis of existing data on PVL-positive S. aureus and MRSA.
- Analysis of reported cases and epidemiological trends of PVL-positive MRSA infections.
- Clinical case study analysis of severe infections caused by PVL-positive MRSA.
Main Results:
- PVL-positive MRSA strains have spread globally, causing life-threatening infections in the UK, Europe, USA, and Australia.
- These superbug strains can cause rapid, fatal infections, even in healthy young individuals, within 24 hours.
- Associated infections range from skin and soft tissue infections to invasive conditions like necrotizing pneumonia.
Conclusions:
- PVL-positive MRSA is a virulent, drug-resistant pathogen posing a significant global health risk.
- The emergence and spread of community-associated PVL-positive MRSA into hospitals increase mortality rates.
- Urgent control strategies are necessary to prevent widespread hospital-acquired infections by PVL-positive MRSA.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Staphylococcal Skin Infections
Bacterial Toxins
Mechanism of Antibiotic Resistance in MRSA
Regulation of Bacterial Virulence
Atypical Pneumonia

